Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

54.15
Delayed Data
As of 4:00pm ET
 +1.87 / +3.58%
Today’s Change
26.80
Today|||52-Week Range
73.54
+20.00%
Year-to-Date
Gilead's (GILD) New HCV Drug Epclusa Wins CHMP Backing
10:39am / Zacks.com - Paid Partner Content
Flexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up
May 27 / Zacks.com - Paid Partner Content
AstraZeneca Reports Positive Phase III Data on Faslodex
9:54am / Zacks.com - Paid Partner Content
Baxalta Reports Positive Phase I Study Data on BAX 930
May 26 / Zacks.com - Paid Partner Content
Intercept's (ICPT) Liver Dug Ocaliva Approved by the FDA
May 30 / Zacks.com - Paid Partner Content
Alkermes Begins Phase I Study on Immuno-Oncology Drug
May 26 / Zacks.com - Paid Partner Content
The Medicines Co. Carbavance TANGO 1 Study Enrolled
May 27 / Zacks.com - Paid Partner Content
Innocoll Stock Gains on Favorable Phase III Data on Xaracoll
May 26 / Zacks.com - Paid Partner Content
Will ANI Pharmaceuticals (ANIP) Continue to Surge Higher?
May 27 / Zacks.com - Paid Partner Content
Alnylam Pharmaceuticals (ALNY) in Focus: Stock Rises 9.9%
May 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close52.28
Today’s open52.85
Day’s range52.63 - 54.66
Volume242,416
Average volume (3 months)222,929
Market cap$600.9M
Dividend yield--
Data as of 4:00pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+34.80%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+36.36%
P/E ratio50.9
Price/Sales6.83
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.22+2.97%
FMIFoundation Medicine ...+0.35+1.89%
RTRXRetrophin Inc+0.31+1.77%
BPMCBlueprint Medicines ...+0.40+2.15%
Data as of 4:00pm ET, 05/31/2016

Financials

Next reporting dateAugust 1, 2016
EPS forecast (this quarter)$0.80
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Partner Offers

Search for Jobs